Results 21 to 30 of about 56,596 (269)

Repurposed itraconazole for use in the treatment of malignancies as a promising therapeutic strategy.

open access: yesBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2022
Understanding cancer biology and the development of novel agents for cancer treatment has always been the goal of cancer researchers. However, the research and development of new drugs is hindered by its long development time, exorbitant cost, high ...
Chun-Lan Li   +5 more
semanticscholar   +1 more source

Itraconazole Inhibits the Growth of Cutaneous Squamous Cell Carcinoma by Targeting HMGCS1/ACSL4 Axis

open access: yesFrontiers in Pharmacology, 2022
Background: Cutaneous squamous cell carcinoma (cSCC) is a common cutaneous cancer with increasing incidence. Itraconazole has been identified as a potential anticancer drug candidate. However, the role of itraconazole in cSCC was still unclear.
Congcong Xu   +3 more
doaj   +1 more source

475. Does Metabolite Matter? Defining Target Itraconazole and Hydroxy-itraconazole Serum Levels for Blastomycosis

open access: yesOpen Forum Infectious Diseases, 2022
Background Itraconazole is first-line treatment for mild-moderate blastomycosis and consolidation of moderate-severe disease. Itraconazole is metabolized to 3 metabolites, including an active metabolite hydroxy-itraconazole.
Danielle Hess   +7 more
semanticscholar   +1 more source

Gender differences in concentration of itraconazole and hydroxyitraconazole [PDF]

open access: yesHalo 194, 2021
Introduction: Itraconazole is an antifungal drug belonging to the triazole group. After oral application, it is rapidly absorbed, but its bioavailability is reduced due to an intensive first-pass through the liver metabolism effect.
Stanojković Tijana   +4 more
doaj   +1 more source

The A756T Mutation of the ERG11 Gene Associated With Resistance to Itraconazole in Candida Krusei Isolated From Mycotic Mastitis of Cows

open access: yesFrontiers in Veterinary Science, 2021
Candida krusei (C. krusei) has been recently recognized as an important pathogen involved in mycotic mastitis of cows. The phenotypic and molecular characteristics of 15 C.
Jun Du   +11 more
doaj   +1 more source

Cardiotoxicity with Itraconazole [PDF]

open access: yesBMJ Case Reports, 2017
Itraconazole is a commonly used antifungal drug. In addition to commonly described adverse effects, there have been few reports of heart failure with its use. We present two cases that developed acute systolic heart failure with Itraconazole use. A man in his early 30s was admitted with worsening leg swelling and dyspnoea on exertion.
Vishesh, Paul, Harsh, Rawal
openaire   +2 more sources

Overexpression of Both ERG11 and ABC2 Genes Might Be Responsible for Itraconazole Resistance in Clinical Isolates of Candida krusei. [PDF]

open access: yesPLoS ONE, 2015
To study the main molecular mechanisms responsible for itraconazole resistance in clinical isolates of Candida krusei.The 14α-demethylases encoded by ERG11 gene in the 16 C.krusei clinical isolates were amplified by polymerase chain reaction (PCR), and ...
Xiaoyuan He   +13 more
doaj   +1 more source

Itraconazole inhibits proliferation, induces apoptosis, and reduces angiogenesis of hemangioma endothelial cells by downregulating the hedgehog signaling pathway

open access: yesHeliyon, 2023
Infantile hemangioma (IH) is among the most prevalent benign vascular tumours in infants. The pathogenesis of IH mainly involves abnormal proliferation of vascular endothelial cells and the formation of new vessels. Itraconazole was shown to be effective
Jianyong Dong   +4 more
doaj   +1 more source

Evaluation of virulence and drug resistance of Sporothrix globosa itraconazole-resistant strains in Galleria mellonella

open access: yesPifu-xingbing zhenliaoxue zazhi, 2020
Objective: To evaluate virulence of itraconazole-resistant Sporothrix globosa and its sensitivity to itraconazole in Galleria mellonella. Methods: Itraconazole-resistant strain and itraconazole-sensitive strain of S.
Jing ZHANG   +4 more
doaj   +1 more source

Itraconazole Exerts its Anti-Tumor Effect in Esophageal Cancer by Suppressing the HER2/AKT Signaling Pathway

open access: yesMolecular Cancer Therapeutics, 2021
Itraconazole, an FDA-approved antifungal, has antitumor activity against a variety of cancers. We sought to determine the effects of itraconazole on esophageal cancer and elucidate its mechanism of action.
Wei Zhang   +23 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy